Lacosamida Teva

Lacosamide, the active ingredient in Lacosamida Teva, is a sodium channel blocker presented as an oral formulation for oral use. It is indicated as adjunctive therapy for partial‑onset seizures in patients with epilepsy. GNH USA supplies Lacosamida Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lacosamida Teva is a sodium channel‑blocking antiepileptic used to manage focal seizure disorders. - Partial‑onset seizures (focal seizures): Adjunctive therapy to reduce seizure frequency in epilepsy patients. - Focal epilepsy: Improves overall seizure control when added to existing antiepileptic regimens. - Refractory focal seizures: Provides additional seizure reduction for patients not adequately controlled by monotherapy.

Lacosamida Teva may cause a range of adverse reactions, some of which are more frequent than others.

Common Side Effects: - Dizziness: Transient sensation of light‑headedness or imbalance. - Headache: Mild to moderate pain in the head region. - Nausea: Stomach upset often occurring after dosing. - Fatigue: Generalised tiredness or reduced energy. - Diplopia: Temporary double vision. - Somnolence: Increased sleepiness during the day.

Serious or Rare Side Effects: - Cardiac arrhythmia: Irregular heart rhythm requiring medical attention. - Suicidal ideation: Thoughts of self‑harm that should be reported immediately. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Cardiac conduction abnormalities: PR‑interval prolongation on ECG. - Hypersensitivity reactions: Anaphylaxis or severe allergic response. - Hepatic dysfunction: Elevated liver enzymes or liver injury.

Before initiating therapy, several safety considerations should be reviewed. - Renal impairment: Assess kidney function and adjust dosing if necessary. - Hepatic impairment: Monitor liver enzymes and consider dose modification. - Concomitant antiepileptics: Watch for additive central nervous system effects. - Pregnancy: Use only if the potential benefit justifies the potential risk to the fetus. - Driving and operating machinery: Caution advised due to possible dizziness or somnolence. - Store at ambient temperature: Keep below 25°C, protect from moisture and light.

Lacosamida Teva can interact with other medicines, influencing its efficacy or safety.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole): May increase lacosamide plasma levels. - Carbamazepine: May reduce lacosamide effectiveness. - Other sodium channel blockers (e.g., phenytoin): Heightened risk of central nervous system depression.

Moderate Interactions (Monitor Closely): - Additional antiepileptics (e.g., valproate): Monitor for additive side effects. - Alcohol: May potentiate sedation and dizziness. - Antihypertensives: Observe blood pressure for possible additive lowering effect.